ClinicalTrials.Veeva

Menu

Validation of OxyVu for Assessing Level of Amputation With Comparison to Other Modalities (LOA)

H

HyperMed Imaging

Status

Unknown

Conditions

Critical Limb Ischemia

Study type

Observational

Funder types

Industry
Other U.S. Federal agency

Identifiers

NCT00767923
2008-011

Details and patient eligibility

About

Correlation of(OxyVu) values to to ABI, TBP, and TCOM in patients scheduled for foot level amputation because of critical limb ischemia, infection, or tissue necrosis.

Full description

The purpose of this clinical study is to correlate tissue oxygenation values measured with a hyperspectral imaging system (OxyVu) to Ankle Brachial Indices (ABI), toe pressures (TBP), and transcutaneous oxygen monitoring (TCOM) in patients scheduled for foot level amputation because of critical limb ischemia, infection, or tissue necrosis.

Enrollment

20 patients

Sex

All

Ages

18 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • 18 to 85 years of age, males and females, varying skin tones, varying racial origins, and with and without diabetes.
  • Patients scheduled for foot level amputation because of critical limb ischemia, infection, or tissue necrosis.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems